These data show that Mga deficiency is not sufficient for an overt hematopoietic malignant phenotype, but do suggest that the loss of Mga may promote a transcriptional and epigenetic landscape that could enhance the aggressive phenotypes of leukemia in the presence of an oncogenic driver. This evidence concerns the gene MGA and leukemia.